Proposed Text of The Labeling of The Drug

First Page		Document Content
Date: 2014-08-01 14:10:14 Glycogen storage disease type II Hepatology Alglucosidase alfa Hypersensitivity Anaphylaxis Medicine Health Allergology		Proposed Text of The Labeling of The Drug Add to Reading List Source URL: www.lumizyme.com Download Document from Source Website File Size: 479,48 KB Share Document on Facebook

	LUMIZYME (alglucosidase alfa) for Injection DocID: 1qeuI - View Document
	May 27, 2014 BioMarin Doses First Patient in Phase 3 INSPIRE Trial With BMN 701 for the Treatment of Pompe Disease Proprietary Glycosylation Independent Lysosomal Targeting (GILT) Tagging Technology Has Been Shown to Im DocID: 1aiEg - View Document
	PDF Document DocID: 17mrV - View Document
	Microsoft WordAlglucosidase Genzyme PSD March 2013 FINAL.doc DocID: 12ze9 - View Document
	Stakeholder meeting outcome statement Alglucosidase alfa (Myozyme®) for the treatment of Late-Onset Pompe Disease A stakeholder meeting was held on 9 October 2014 to discuss the development of eligibility guidelines for DocID: 11ce5 - View Document